IBDEI158 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20480,1,5,0)
 ;;=5^SJS-TEN Syndrome
 ;;^UTILITY(U,$J,358.3,20480,2)
 ;;=^336637
 ;;^UTILITY(U,$J,358.3,20481,0)
 ;;=695.15^^131^1288^71
 ;;^UTILITY(U,$J,358.3,20481,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20481,1,4,0)
 ;;=4^695.15
 ;;^UTILITY(U,$J,358.3,20481,1,5,0)
 ;;=5^Toxic Epidermal Necrolysis
 ;;^UTILITY(U,$J,358.3,20481,2)
 ;;=^336638
 ;;^UTILITY(U,$J,358.3,20482,0)
 ;;=695.19^^131^1288^30
 ;;^UTILITY(U,$J,358.3,20482,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20482,1,4,0)
 ;;=4^695.19
 ;;^UTILITY(U,$J,358.3,20482,1,5,0)
 ;;=5^Erythema Multiforme NEC
 ;;^UTILITY(U,$J,358.3,20482,2)
 ;;=^336639
 ;;^UTILITY(U,$J,358.3,20483,0)
 ;;=V18.0^^131^1289^15
 ;;^UTILITY(U,$J,358.3,20483,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20483,1,4,0)
 ;;=4^V18.0
 ;;^UTILITY(U,$J,358.3,20483,1,5,0)
 ;;=5^Family h/o Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,20483,2)
 ;;=^295311
 ;;^UTILITY(U,$J,358.3,20484,0)
 ;;=V16.0^^131^1289^7
 ;;^UTILITY(U,$J,358.3,20484,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20484,1,4,0)
 ;;=4^V16.0
 ;;^UTILITY(U,$J,358.3,20484,1,5,0)
 ;;=5^Family h/o Cancer of GI Tract
 ;;^UTILITY(U,$J,358.3,20484,2)
 ;;=^295292
 ;;^UTILITY(U,$J,358.3,20485,0)
 ;;=V16.1^^131^1289^8
 ;;^UTILITY(U,$J,358.3,20485,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20485,1,4,0)
 ;;=4^V16.1
 ;;^UTILITY(U,$J,358.3,20485,1,5,0)
 ;;=5^Family h/o Cancer of Lung
 ;;^UTILITY(U,$J,358.3,20485,2)
 ;;=^295293
 ;;^UTILITY(U,$J,358.3,20486,0)
 ;;=V19.6^^131^1289^1
 ;;^UTILITY(U,$J,358.3,20486,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20486,1,4,0)
 ;;=4^V19.6
 ;;^UTILITY(U,$J,358.3,20486,1,5,0)
 ;;=5^Family h/o Allergic Disorder
 ;;^UTILITY(U,$J,358.3,20486,2)
 ;;=^295326
 ;;^UTILITY(U,$J,358.3,20487,0)
 ;;=V18.2^^131^1289^2
 ;;^UTILITY(U,$J,358.3,20487,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20487,1,4,0)
 ;;=4^V18.2
 ;;^UTILITY(U,$J,358.3,20487,1,5,0)
 ;;=5^Family h/o Anemia
 ;;^UTILITY(U,$J,358.3,20487,2)
 ;;=^295313
 ;;^UTILITY(U,$J,358.3,20488,0)
 ;;=V17.5^^131^1289^4
 ;;^UTILITY(U,$J,358.3,20488,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20488,1,4,0)
 ;;=4^V17.5
 ;;^UTILITY(U,$J,358.3,20488,1,5,0)
 ;;=5^Family h/o Asthma
 ;;^UTILITY(U,$J,358.3,20488,2)
 ;;=^295307
 ;;^UTILITY(U,$J,358.3,20489,0)
 ;;=V17.7^^131^1289^3
 ;;^UTILITY(U,$J,358.3,20489,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20489,1,4,0)
 ;;=4^V17.7
 ;;^UTILITY(U,$J,358.3,20489,1,5,0)
 ;;=5^Family h/o Arthritis
 ;;^UTILITY(U,$J,358.3,20489,2)
 ;;=^295309
 ;;^UTILITY(U,$J,358.3,20490,0)
 ;;=V19.0^^131^1289^5
 ;;^UTILITY(U,$J,358.3,20490,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20490,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,20490,1,5,0)
 ;;=5^Family h/o Blindness
 ;;^UTILITY(U,$J,358.3,20490,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,20491,0)
 ;;=V16.3^^131^1289^6
 ;;^UTILITY(U,$J,358.3,20491,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20491,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,20491,1,5,0)
 ;;=5^Family h/o Cancer of Breast
 ;;^UTILITY(U,$J,358.3,20491,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,20492,0)
 ;;=V16.41^^131^1289^9
 ;;^UTILITY(U,$J,358.3,20492,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20492,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,20492,1,5,0)
 ;;=5^Family h/o Cancer of Ovary
 ;;^UTILITY(U,$J,358.3,20492,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,20493,0)
 ;;=V16.42^^131^1289^10
 ;;^UTILITY(U,$J,358.3,20493,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20493,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,20493,1,5,0)
 ;;=5^Family h/o Cancer of Prostate
 ;;^UTILITY(U,$J,358.3,20493,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,20494,0)
 ;;=V16.43^^131^1289^11
